Amanote Research
Register
Sign In
Prediction of the Clinical Chemotherapeutic Response of Stage III Lung Adenocarcinoma Patients by an in Vitro Short Term Test
British Journal of Cancer
- United Kingdom
doi 10.1038/bjc.1988.42
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
February 1, 1988
Authors
M Volm
P Drings
EW Hahn
J Mattern
Publisher
Springer Science and Business Media LLC
Related search
Classification and Survival Prediction for Early‑stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients
Oncology Letters
Cancer Research
Oncology
P2.09-26 Clinical Significance of Subcellular Localization of Maspin in Patients With Pathological Stage IA Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinical Predictive Value of in Vitro Anticancer Drug Sensitivity Test for the Therapeutic Effect of Adjuvant Chemotherapy in Patients With Stage II–III Colorectal Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Stratifin Accelerates Progression of Lung Adenocarcinoma at an Early Stage
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Left Lung Torsion: Complication of Lobar Resection for an Early Stage Lung Adenocarcinoma
Case Reports in Critical Care
Phase 2 Trial of Neoadjuvant Bevacizumab Plus Pemetrexed and Carboplatin in Patients With Unresectable Stage III Lung Adenocarcinoma (GASTO 1001)
Cancer
Cancer Research
Oncology
Tumor Spread Through Air Space (STAS) Is an Important Predictor of Clinical Outcome in Stage IA Lung Adenocarcinoma
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Short Term Prediction of Infectious Diseases Patients From Prescription Surveillance
Journal of Biosciences and Medicines
Short-Term Postoperative Complications and Prognostic Factors in Patients With Adenocarcinoma of the Esophagogastric Junction
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
